Spencer Pharmaceutical Inc. (SPPH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 22, 2026
Spencer Pharmaceutical Market Cap
Spencer Pharmaceutical has a market cap or net worth of $271 as of January 23, 2026. Its market cap has decreased by -99.89% in one year.
Market Cap
271.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 8, 2010, Spencer Pharmaceutical's market cap has decreased from 32.47M to 271.00, a decrease of -100.00%. That is a compound annual growth rate of -52.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 271.00 | - |
| Dec 23, 2025 | 271.00 | - |
| Dec 7, 2023 | 271.00 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Eloxx Pharmaceuticals | 330.00 |
| Nabriva Therapeutics | 323.00 |
| Alzex Neuropharma | 301.00 |
| Nanobac Pharmaceuticals | 250.00 |
| NanoLogix | 163.00 |
| Regenicin | 153.00 |